Information About Ipsen
Ipsen is a global biopharmaceutical Group dedicated to improving lives through innovative medicines in Oncology, Neuroscience and Rare Diseases. We also have a well-established and successful Consumer Healthcare business. We are committed to discovering new solutions for targeting debilitating diseases and improving the quality of life for patients.
The Group was founded in 1929 and, by its 91th anniversary, operates in 37 countries, with about 5.7 thousand employees worldwide.
Ipsen's portfolio includes 20 drugs in the field of Neurology, Oncology, Endocrinology, Gynecology, Consumer Healthcare and Aesthetic medicine.
The company is headquartered in Paris (France).
5 facts about Ipsen
Ipsen in Oncology
Ipsen is one of the 14 largest pharmaceutical companies in the world developing drugs for the treatment of cancer.
Ipsen currently has a dedicated cancer portfolio for the treatment of neuroendocrine tumors, cancer of the bladder, prostate, pancreas, lung cancer, breast and kidney.
Ipsen in Russia & CIS
Ipsen has been present in Russia since 1993, here are 10 of the company's drugs used in general therapeutic practice, in the field of Specialty Care, including aesthetic medicine. The company has about 300 employees.
Russia leads the Ipsen cluster in the CIS, consisting of 10 countries.
The company has been present in Kazakhstan since 1994.
There are 5 business units in Ipsen Russia and Kazakhstan:
1) CHC
2) Oncology
3) Neurology
4) Rare diseases
5) Aesthetics.
More information about Ipsen and its products can be found on our website: https://www.ipsen.com/russia/.